期刊文献+

高效液相色谱法测定L-肌肽原料药的含量及其有关物质 被引量:5

Determination of L-Carnosine and Its Related Substances by HPLC
原文传递
导出
摘要 目的建立HPLC测定L-肌肽原料药的含量并进行有关物质检查。方法采用KromasilNH2色谱柱(4.6mm×200mm,5μm),流动相为乙腈-40mmol·L-1磷酸氢二钾溶液(44∶56,磷酸调pH6.3),流速1.0mL·min-1,检测波长为210nm,柱温35℃。结果L-肌肽在9.93~99.3mg·L-1内线性关系良好(r=0.9998),平均回收率为100.5%(RSD=1.0%),检测限为1ng(S/N=3)。L-肌肽与有关物质分离良好。结论该方法操作简便、重复性好、专属性强,可用作L-肌肽原料药的含量测定和有关物质检查。 OBJECTIVE To establish a HPLC method for determining the content of L-carnosine and its related substances. METHODS The determination of L-carnosine and the separation of its related substances was performed on a Kromasil NH2 column (4.6 mm×200 mm, 5 μm).The mobile phase consisted of acetonitrile-methanol -40 mmol.Ll dibasic potassium phosphate (44 : 56, adjusted pH to 6.3 with Phosphoric acid).The flow rate was 1.0 mL·min^-1. Ultraviolet absorption detector was set at 210 nm and column temperature at 35 ℃. RESULTS The linearity of L-carnosine was in the range of 9.8 to 98 mg·L^-1 (r=0.999 8). The average recovery was 100.5% with RSD of 1.0%. The related substances of L-camosine were completely separated from L-carnosine. The limit of detection (LOD) was 1 ng (S/N=3) . CONCLUSION A reproducible and specific method is provided for the determination of L-carnosine and its related substances.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第14期1111-1113,共3页 Chinese Pharmaceutical Journal
关键词 高效液相色谱法 L-肌肽 含量测定 相关物质 HPLC, L-carnosine quantitative determination related substances
  • 相关文献

参考文献3

二级参考文献26

  • 1王爱民,董军,王保安,马波,范业鹏,王剑.肌肽和SOD对自由基清除作用的比较[J].基础医学与临床,1995,15(1):74-74. 被引量:16
  • 2[18]Seidler NW,Yeargans GS.Effects of thermal denaturation on protein glycation.Life Sci,2002; 70 (15):1789-1799.
  • 3[19]Yeargans GS,Seidler NW.Carnosine promotes the heat denaturation of glycated protein.Biochem Biophys Res Commun,2003; 300(1):75-80.
  • 4[20]Seidler NW.Carnosine prevents the glycation-induced changes in electrophoretic mobility of aspartate aminotransferase.Biochem Mol Toxicol,2000; 14 (4):215-220.
  • 5[21]Babizhayev MA,Deyev AI,Yermakova VN,et al.Efficacy of N-acetylcarnosine in the treatment of cataracts.Drugs R D,2002;3(2):87-103.
  • 6[22]Hipkiss AR,Worthington VC,Himsworth DT,et al.Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite.Biochim Biophys Acta,1998; 1380 (1):46-54.
  • 7[23]Hipkiss AR,Chana H.Carnosine protects proteins against methylglyoxal-mediated modifications.Biochem Biophys Res Commun,1998; 248 (1):28-32.
  • 8[24]Hobart LJ,Seibel I,Yeargans GS,et al.Anticrosslinking properties of carnosine:Significance of histidine.Life Sci,2004; 75 (11):1379-1389.
  • 9[1]Babizhayev MA,Dey ev AI,Yermakova VN,et al.Lipid peroxidation and cataracts:N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.Drugs R D,2004;5(3):125-139.
  • 10[2]Wang AM,Ma C,Xie ZH,et al.Use of carnosine as a natural anti-senescence drug for human beings.Biochemistry (Mosc),2000; 65 (7):869-871.

共引文献12

同被引文献64

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部